SEC Form 4 · accession 0001127602-17-019148
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vecheslav A Elagin
Officer — EVP, R&D & Chf Scientific Off
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 1:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 79 | I | Held in Meridian Savings & Investment Plan (401K) | |
| Common Stock | holding | — | — | — | 52,926 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $13.60 | May 19, 2017 | A | 10,000 | A | — | May 19, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1These options are awarded under the 2012 Stock Incentive Plan in connection with promotion to Executive Vice President, Research & Development and Chief Scientific Officer, and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on May 19, 2021).